Clinical trial Recruiting at 1 site Interventional Ages 20 to 65

Fistula Rerouting versus LIFT for high perianal fistula

Official title: Comparative Study Between Fistula Rerouting Technique and Ligation of Intersphincteric Fistula Tract (LIFT) Technique in Treatment of High Perianal Fistula.

Run by Cairo University · NCT07399353 · Data updated 2026-11-12

This trial will test whether the Fistula Rerouting technique or the LIFT operation works better for adults with high perianal fistula by comparing recurrence and bowel-control after surgery.

Quick facts

Study typeInterventional
Ages20 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Al-Manial Cairo)
StatusRecruiting
StartedAugust 28, 2025
Main results expectedMay 2026
Study endsJune 2026
Registry record updatedFebruary 10, 2026
Trial IDNCT07399353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–65 with confirmed high trans-sphincteric or extrasphincteric perianal fistula (including recurrent cases) who can consent and tolerate spinal/general anesthesia are ideal candidates.

Probably not a fit

Patients with preoperative fecal incontinence, inflammatory bowel disease (e.g., Crohn's), complex branching fistula tracts, pregnancy, or age under 20 are unlikely to be eligible or benefit from these specific procedures.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, controlled, parallel-group surgical trial comparing two sphincter-preserving operations for high perianal fistula: staged Fistula Rerouting Technique (FRT) and Ligation of the Intersphincteric Fistula Tract (LIFT). Adult participants will undergo preoperative assessment including MRI to confirm fistula anatomy, then be randomly assigned to one of the two surgical procedures. Primary outcome is postoperative fistula recurrence and a key secondary outcome is postoperative fecal continence, measured with standardized scoring and follow-up exams. The trial excludes patients with preoperative incontinence, inflammatory bowel disease, complex branching tracts, pregnancy, or contraindications to anesthesia.

Why it matters

Potential benefit: If one technique proves superior, patients could have fewer recurrences and better preservation of bowel control after surgery.

How similar studies have gone: The LIFT procedure has shown reasonable success in multiple series since 2007, while Fistula Rerouting has been described previously, but direct head-to-head comparative data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (age 20-65 years) presenting with a high perianal fistula, defined as:Trans-sphincteric fistula tract traversing the upper two-thirds of the external anal sphincter, Or Extrasphincteric fistula.
* Patients with recurrent perianal fistula.
* Ability to provide informed consent.

Exclusion Criteria:

* Patients with preoperative fecal incontinence (as assessed by the Cleveland Clinic Fecal Incontinence Score).
* Diagnosis of inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis).
* Pregnant women.
* Pediatric patients (age \< 20 years).
* Patients with complex, branching fistula tracts.
* Any contraindication to spinal/general anesthesia or surgery.

Where it's running

  • Faculty of Medicine Cairo University
    Cairo, Al-Manial Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.